These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 31208268
1. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide. Datta AN, Michoulas A, Guella I, EPGEN Study3 University of British Columbia, Vancouver, British Columbia, Canada.EPGEN Study investigators include Shelin Adam, Cyrus Boelman, Corneliu Bolbocean, Sarah E. Buerki, Tara Candido, Patrice Eydoux, Daniel M. Evans, William Gibson, Gabriella Horvath, Linda Huh, Tanya N. Nelson, Graham Sinclair, Tamsin Tarling, Eric B. Toyota, Katelin N. Townsend, Margot I. Van Allen, Clara van Karnebeek, and Suzanne Vercauteren., Demos M. J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268 [Abstract] [Full Text] [Related]
2. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP. Kuchenbuch M, Barcia G, Chemaly N, Carme E, Roubertie A, Gibaud M, Van Bogaert P, de Saint Martin A, Hirsch E, Dubois F, Sarret C, Nguyen The Tich S, Laroche C, des Portes V, Billette de Villemeur T, Barthez MA, Auvin S, Bahi-Buisson N, Desguerre I, Kaminska A, Benquet P, Nabbout R. Brain; 2019 Oct 01; 142(10):2996-3008. PubMed ID: 31532509 [Abstract] [Full Text] [Related]
3. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report. Takase C, Shirai K, Matsumura Y, Watanabe T, Watanabe A, Hirasawa-Inoue A, Mizuguchi T, Matsumoto N, Sugai K, Hayashi M. Brain Dev; 2020 Sep 01; 42(8):607-611. PubMed ID: 32505479 [Abstract] [Full Text] [Related]
4. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum. Bonardi CM, Heyne HO, Fiannacca M, Fitzgerald MP, Gardella E, Gunning B, Olofsson K, Lesca G, Verbeek N, Stamberger H, Striano P, Zara F, Mancardi MM, Nava C, Syrbe S, Buono S, Baulac S, Coppola A, Weckhuysen S, Schoonjans AS, Ceulemans B, Sarret C, Baumgartner T, Muhle H, Portes VD, Toulouse J, Nougues MC, Rossi M, Demarquay G, Ville D, Hirsch E, Maurey H, Willems M, de Bellescize J, Altuzarra CD, Villeneuve N, Bartolomei F, Picard F, Hornemann F, Koolen DA, Kroes HY, Reale C, Fenger CD, Tan WH, Dibbens L, Bearden DR, Møller RS, Rubboli G. Brain; 2021 Dec 31; 144(12):3635-3650. PubMed ID: 34114611 [Abstract] [Full Text] [Related]
5. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy. Dilena R, DiFrancesco JC, Soldovieri MV, Giacobbe A, Ambrosino P, Mosca I, Galli MA, Guez S, Fumagalli M, Miceli F, Cattaneo D, Darra F, Gennaro E, Zara F, Striano P, Castellotti B, Gellera C, Varesio C, Veggiotti P, Taglialatela M. Neurotherapeutics; 2018 Oct 31; 15(4):1112-1126. PubMed ID: 30112700 [Abstract] [Full Text] [Related]
9. Lack of response to quinidine in KCNT1-related neonatal epilepsy. Numis AL, Nair U, Datta AN, Sands TT, Oldham MS, Patel A, Li M, Gazina E, Petrou S, Cilio MR. Epilepsia; 2018 Oct 31; 59(10):1889-1898. PubMed ID: 30182418 [Abstract] [Full Text] [Related]
10. Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy. McTague A, Nair U, Malhotra S, Meyer E, Trump N, Gazina EV, Papandreou A, Ngoh A, Ackermann S, Ambegaonkar G, Appleton R, Desurkar A, Eltze C, Kneen R, Kumar AV, Lascelles K, Montgomery T, Ramesh V, Samanta R, Scott RH, Tan J, Whitehouse W, Poduri A, Scheffer IE, Chong WKK, Cross JH, Topf M, Petrou S, Kurian MA. Neurology; 2018 Jan 02; 90(1):e55-e66. PubMed ID: 29196579 [Abstract] [Full Text] [Related]
14. Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review. Gras M, Bearden D, West J, Nabbout R. Epilepsia Open; 2024 Aug 02; 9(4):1176-1191. PubMed ID: 39093319 [Abstract] [Full Text] [Related]
17. Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy. Miziak B, Czuczwar SJ. Expert Opin Drug Discov; 2022 Dec 02; 17(12):1313-1328. PubMed ID: 36408599 [Abstract] [Full Text] [Related]
18. Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature. Abdelnour E, Gallentine W, McDonald M, Sachdev M, Jiang YH, Mikati MA. Seizure; 2018 Feb 02; 55():1-3. PubMed ID: 29291456 [Abstract] [Full Text] [Related]
19. Potassium Channel Subfamily T Member 1(KCNT1) Pathological Variant Causing Epilepsy Of Infancy With Migrating Focal Seizures: A Case Report. Chand P, Angez M, Hameed AN, Kirmani S. J Pak Med Assoc; 2023 Aug 02; 73(8):1720-1722. PubMed ID: 37697770 [Abstract] [Full Text] [Related]
20. Treatment Responsiveness in KCNT1-Related Epilepsy. Fitzgerald MP, Fiannacca M, Smith DM, Gertler TS, Gunning B, Syrbe S, Verbeek N, Stamberger H, Weckhuysen S, Ceulemans B, Schoonjans AS, Rossi M, Demarquay G, Lesca G, Olofsson K, Koolen DA, Hornemann F, Baulac S, Rubboli G, Minks KQ, Lee B, Helbig I, Dlugos D, Møller RS, Bearden D. Neurotherapeutics; 2019 Jul 02; 16(3):848-857. PubMed ID: 31054119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]